|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.53 HKD | +9.71% |
|
+14.88% | -23.70% |
| 06-25 | 3Sbio Inc. Declares a Final Dividend for the Year Ended 31 December 2025 | CI |
| 05-28 | Innovent Biologics, Pfizer strike $10.5 bln cancer drug deal amid China biotech boom | RE |
| Market Cap | 36.59B 42.24B 5.38B 4.73B 4.35B 4.06B 7.65B 512B 7.8B 52.34B 20.28B 251B 20.22B 19.78B 875B | P/E 2026 * |
13.4x | P/E 2027 * | 12.6x |
|---|---|---|---|---|---|
| Enterprise Value | 24.02B 27.73B 3.54B 3.1B 2.86B 2.66B 5.02B 336B 5.12B 34.37B 13.31B 165B 13.27B 12.99B 574B | EV / Sales 2026 * |
2.3x | EV / Sales 2027 * | 1.97x |
| Free-Float |
74.93% | Yield 2026 * |
1.68% | Yield 2027 * | 1.86% |
| 1 day | +9.24% | ||
| 1 week | +14.88% | ||
| Current month | +9.24% | ||
| 1 month | +9.37% | ||
| 3 months | -27.30% | ||
| 6 months | -24.94% | ||
| Current year | -23.70% |
| 1 week | 15.62 |  | 19.08 |
| 1 month | 14.81 | | 19.08 |
| Current year | 14.81 | | 29.3 |
| 1 year | 14.81 | | 36.8 |
| 3 years | 4.91 | | 36.8 |
| 5 years | 4.72 | | 36.8 |
| 10 years | 4.72 | | 36.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jing Lou
CEO | Chief Executive Officer | 63 | 2005-12-31 |
Xiang He
DFI | Director of Finance/CFO | - | 2023-07-02 |
Dong Mei Su
PRN | Corporate Officer/Principal | 56 | 2014-11-26 |
| Director | Title | Age | Since |
|---|---|---|---|
Jing Lou
CHM | Chairman | 63 | 2012-04-02 |
Dong Mei Su
BRD | Director/Board Member | 56 | 2012-06-10 |
Tian Ruo Pu
BRD | Director/Board Member | 57 | 2015-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-07 | Other | Chief Executive Officer | 516,000 | 0.0203% | ||
| 25-07-28 | Other | Chief Executive Officer | 440,000 | 0.0184% | ||
| 25-04-14 | Other | Director | 26,000 | 0.0011% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9.71% | +14.88% | -23.92% | +145.35% | 5.39B | |
| +0.19% | +0.21% | +16.79% | -13.06% | 63.44B | |
| -1.56% | +1.14% | +54.57% | +217.61% | 56.98B | |
| +0.36% | +39.60% | +39.60% | +39.60% | 41.58B | |
| -0.30% | +0.31% | -50.78% | -57.28% | 38.01B | |
| -2.93% | +5.09% | +61.25% | -26.37% | 31.9B | |
| +3.53% | +19.99% | +152.70% | -40.33% | 27.79B | |
| +0.40% | +4.93% | +65.59% | +82.83% | 22.65B | |
| +7.60% | +12.09% | +7.57% | +184.33% | 17.64B | |
| +1.34% | -0.64% | +64.17% | +122.53% | 16.49B | |
| Average | +1.74% | +4.40% | +38.75% | +65.52% | 32.19B | |
| Weighted average by Cap. | +0.43% | +3.68% | +39.26% | +52.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10.45B 12.06B 1.54B 1.35B 1.24B 1.16B 2.18B 146B 2.23B 14.94B 5.79B 71.75B 5.77B 5.65B 250B | 11.29B 13.03B 1.66B 1.46B 1.34B 1.25B 2.36B 158B 2.41B 16.15B 6.26B 77.55B 6.24B 6.1B 270B |
| Net income | 2.83B 3.26B 416M 365M 336M 313M 591M 39.55B 603M 4.04B 1.57B 19.41B 1.56B 1.53B 67.56B | 2.95B 3.41B 434M 381M 351M 327M 617M 41.3B 630M 4.22B 1.64B 20.27B 1.63B 1.6B 70.56B |
| Net Debt | -12.56B -14.5B -1.85B -1.62B -1.49B -1.39B -2.63B -176B -2.68B -17.98B -6.96B -86.3B -6.94B -6.79B -300B | -14.36B -16.58B -2.11B -1.86B -1.71B -1.59B -3B -201B -3.06B -20.55B -7.96B -98.66B -7.94B -7.77B -343B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-01 | HK$18.53 | +9.71% | 31,833,457 |
| 26-06-30 | HK$16.89 | -2.26% | 29,240,677 |
| 26-06-29 | HK$17.28 | +8.61% | 53,608,189 |
| 26-06-26 | HK$15.91 | -0.93% | 25,420,952 |
| 26-06-25 | HK$16.06 | -2.19% | 32,683,363 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1530 Stock
Select your edition
All financial news and data tailored to specific country editions
